Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. I. Single-dose study. (Q54120900)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. I. Single-dose study. |
scientific article |
Statements
Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. I. Single-dose study. (English)
1 reference
Acocella G
1 reference
Nonis A
1 reference
Gialdroni-Grassi G
1 reference
Grassi C
1 reference
1 October 1988
1 reference
138
1 reference
4
1 reference
882-885
1 reference
Identifiers
1 reference